Sfoglia per AUTORE
SATOLLI MA
Collezione AOU Città della Salute di Torino

  

Items : 23

Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance. in Cancer investigation / Cancer Invest. 2025 Jan;43(1):59-69. doi: 10.1080/07357907.2024.2432013. Epub 2024 Nov 27.
2025
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino

Di Maio M; Brunetti O; Spadi R; Ilaria D; Rimini M; Tavolari S; Palloni A; Deserti M; Scartozzi M; Faloppi L; Santini D; Lutrino SE; Aprile G; Sperti E; Salani F; Silvestris N; Satolli MA; Casadei-Gardini A; Leone F; Filippi R; Brandi G;

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.
2024
ASL Biella
AOU Città della Salute di Torino

Aldrighetti L; Ratti F; De Rosa A; Zanuso V; Niger M; Fornaro L; Rossari F; Satolli MA; Garattini SK; Brandi G; Brunetti O; Leone F; Diana A; Pirrone C; Toma I; Pretta A; Landriscina M; Lorenzo A; Gusmaroli E; Bergamo F; Balsano R; Winchler C; Salani F; Formica V; Schirripa M; Aprile G; Garajova I; Martinelli E; Rapposelli IG; et alii...

2024
AOU Città della Salute di Torino

Cappello P; Giordano D; Campra D; Satolli MA; Spadi R; Genuardi E; Bonello L; Arigoni M; Calogero R; Curcio C; Bulfamante S; Brugiapaglia S; Cordero F; Novelli F;

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma. in Cancer medicine / Cancer Med. 2023 Jul;12(13):14337-14345. doi: 10.1002/cam4.6111. Epub 2023 Jun 6.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Casalino S; Spadi R; Zaniboni A; Scartozzi M; Antonuzzo L; Milella M; De Vita F; Barsotti G; Zecchetto C; Pinto C; Zichi C; Giordano G; Satolli MA; Noventa S; Pretta A; Giommoni E; Vaccaro V; Fasano M; Merz V; Procaccio L; Bergamo F; De Toni C; Melisi D; Lonardi S;

Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival. in Clinical and experimental medicine / Clin Exp Med. 2023 Dec;23(8):5089-5100. doi: 10.1007/s10238-023-01236-5. Epub 2023 Nov 1.
2023
AOU Città della Salute di Torino

Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F;

Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy. in Frontiers in oncology / Front Oncol. 2023 Apr 5;13:1128930. doi: 10.3389/fonc.2023.1128930. eCollection 2023.
2023
ASL Biella
AOU Città della Salute di Torino

Lonardi S; Aprile G; Rizzo A; Satolli MA; Aglietta M; Silvestris N; Santini D; Faloppi L; Scartozzi M; Leone F; Brandi G; Fornaro L; Casadei-Gardini A;

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Dec;34(8):543-549. doi: 10.1080/1120009X.2022.2036557. Epub 2022 Feb 14.
2022
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cucchetti A; Ratti F; Aldrighetti L; Cascinu S; Burgio V; Faloppi L; Sperti E; Pellino A; Scartozzi M; Satolli MA; Salani F; Fenocchio E; Vivaldi C; Aprile G; Frega G; Aglietta M; Masi G; Filippi R; Galizia E; Palloni A; Santini D; Lonardi S; Lai E; Montagnani F; Pella N; Silvestris N; Fornaro L; Brandi G; Leone F; et alii...

Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Apr;34(2):123-132. doi: 10.1080/1120009X.2021.1953887. Epub 2021 Jul 27.
2022
ASL Biella
AOU Città della Salute di Torino

Brandi G; Brunetti O; Aglietta M; Giulia O; Fenocchio E; Spadi R; Garattini SK; Vivaldi C; Lombardi P; Frega G; Russano M; Lutrino SE; Scartozzi M; Satolli MA; Palloni A; Casadei-Gardini A; Silvestris N; Aprile G; Fornaro L; Leone F; Filippi R;

2022
ASL Torino 4
AOU Città della Salute di Torino

Berardi R; Galassi B; Ferri C; Garrone O; Zoratto F; Ciardiello D; Pensieri MV; Tomao S; Depetris I; Di Pietro FR; Dell'Aquila E; Giordano G; Landriscina M; Vitale P; Zurlo IV; De Tursi M; Di Marino P; Daniele B; Satolli MA; Petrillo A; Strippoli A; Filippi R; Bensi M; Maratta MG; Salvatore L; Ghidini M; Felicetti C; Giampieri R; Mammarella A; et alii...

A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2021 Oct;60(10):1317-1324. doi: 10.1080/0284186X.2021.1953704. Epub 2021 Jul 20.
2021
ASL Biella
AOU Città della Salute di Torino

Brandi G; Aglietta M; Rimini M; Rovesti G; Silvestris N; Lutrino SE; Vivaldi C; Citarella F; Scartozzi M; Satolli MA; Palloni A; Casadei-Gardini A; Faloppi L; Aprile G; Fornaro L; Leone F; Lombardi P; Montagnani F; Filippi R;

IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions. in Proceedings of the National Academy of Sciences of the United States of America / Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2020395118. doi: 10.1073/pnas.2020395118.
2021
AOU Città della Salute di Torino

Mucciolo G; Curcio C; Roux C; Li WY; Capello M; Curto R; Chiarle R; Giordano D; Satolli MA; Lawlor R; Scarpa A; Lukac P; Stakheev D; Provero P; Vannucci L; Mak TW; Novelli F; Cappello P;

Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2021 Apr;22(6):677-684. doi: 10.1080/14656566.2021.1876664. Epub 2021 Feb
2021
AOU Città della Salute di Torino

Depetris I; Satolli MA; Filippi R;

In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001071. doi: 10.1136/jitc-2020-001071.
2020
AOU Città della Salute di Torino

Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F;

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Hanash SM; Evangelista A; Satolli MA; Spadi R; Giordano D; Momin AA; Capello M; Hong W; Katayama H; Ferrero G; Follia L; Mandili G; Cordero F; Novelli F;

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.
2019
ASL Biella
ASL VCO
AO Ordine Mauriziano
AOU Città della Salute di Torino

Lièvre A; Montagnani F; Vasile E; Brac C; Aglietta M; Clerico M; Passardi A; Buscaglia P; Meurisse A; Pasquini G; Neuzillet C; Falcone A; Spadi R; Edeline J; Sperti E; Musettini G; Satolli MA; Vernerey D; De Luca E; Vivaldi C; Lombardi P; Vienot A; Casadei-Gardini A; Leone F; Fornaro L;

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. in Frontiers in oncology / Front Oncol. 2019 Feb 27;9:115. doi: 10.3389/fonc.2019.00115. eCollection 2019.
2019
AOU Città della Salute di Torino

Follia L; Ferrero G; Mandili G; Beccuti M; Giordano D; Spadi R; Satolli MA; Evangelista A; Katayama H; Hong W; Momin AA; Capello M; Hanash SM; Novelli F; Cordero F;

Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. in Medical oncology (Northwood, London, England) / Med Oncol. 2018 Oct 4;35(12):150. doi: 10.1007/s12032-018-1211-7.
2018
AOU Città della Salute di Torino

Martini S; Arcadipane F; Strignano P; Spadi R; Contu V; Fiandra C; Ragona R; Catalano G; Satolli MA; Camandona M; Romagnoli R; Ricardi U; Franco P; Martini S; Arcadipane F; Strignano P; Spadi R; Contu V; Fiandra C; Ragona R; Catalano G; Satolli MA; Camandona M; Romagnoli R; Ricardi U; Franco P;

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. in PloS one / PLoS One. 2018 Jan 19;13(1):e0191593. doi: 10.1371/journal.pone.0191593. eCollection 2018.
2018
AOU Città della Salute di Torino

Spadi R; Avallone A; Reni M; Aprile G; Satolli MA; Nasti G; Cereda S; Gammaitoni L; Cagnazzo C; Fenocchio E; Cavalloni G; Peraldo-Neia C; Venesio T; Martin V; Doglioni C; Frattini M; Aglietta M; Leone F;

Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. in Medical oncology (Northwood, London, England) / Med Oncol. 2017 Mar;34(3):40. doi: 10.1007/s12032-017-0898-1. Epub 2017 Feb 7.
2017
AOU Città della Salute di Torino

Franco P; Arcadipane F; Strignano P; Spadi R; Trino E; Martini S; Iorio GC; Satolli MA; Airoldi M; Romagnoli R; Camandona M; Ricardi U;

Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. in World journal of clinical oncology / World J Clin Oncol. 2016 Feb 10;7(1):27-43. doi: 10.5306/wjco.v7.i1.27.
2016
AOU Città della Salute di Torino

Spadi R; Brusa F; Ponzetti A; Chiappino I; Birocco N; Ciuffreda L; Satolli MA;

Intra-tumoral IFN-?-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer. in Clinical science (London, England : 1979) / Clin Sci (Lond). 2016 Feb;130(4):247-58. doi: 10.1042/CS20150437. Epub 2015 Nov 20.
2016
AOU Città della Salute di Torino

Novelli F; Prisco D; Bani D; Cianchi F; Coratti A; Satolli MA; Giordano D; Castiglione F; Ringressi MN; Pini A; Bencini L; Bechi P; Benagiano M; D'Elios MM; Ricci F; Rolla S; Niccolai E; Taddei A; Amedei A;

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2015 Feb 5;34(1):10. doi: 10.1186/s13046-015-0122-0.
2015
AOU Città della Salute di Torino

Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; et alii...

Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663. Epub 2014 Mar 25.
2014
AOU Città della Salute di Torino

Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M;